Status:
RECRUITING
A Case-control Study on the Clinical Characteristics of 28-day and 90-day Death From Severe Anthrax
Lead Sponsor:
Qin Ning
Conditions:
Anthrax
Eligibility:
All Genders
18+ years
Brief Summary
This study is a clinical, multi-center, retrospective, case-control study. Patients clinically diagnosed with severe anthrax who meet the inclusion and exclusion criteria will be included in this stud...
Eligibility Criteria
Inclusion Criteria:
- The typical bacilli with capsules were found in smear examination and culture of various secretions, excretions, blood and cerebrospinal fluid.
- Multiple organ dysfunction (MODS) in brain, heart, liver, kidney, coagulation or more than one organ failure.
Exclusion Criteria:
There are other conditions that affect short-term survival.
Key Trial Info
Start Date :
March 13 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06365073
Start Date
March 13 2024
End Date
December 31 2024
Last Update
April 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China